From the Sector

• Significant improvement in the third quarter after COVID-19-related slump on the fiber market
• Measures for structural earnings improvement with positive impact
• Strategic investment projects remain on track
• Hygiene Austria joint venture: Successful growth and continued focus on certified protective masks
• Lenzing wins the Austrian State Prize for Innovation with LENZING™ Web Technology

Lenzing – In the first three quarters of 2020, the Lenzing Group successfully responded to the extremely difficult market environment of increased pressure on prices and volume due to the COVID-19 crisis by implementing a broad package of measures and remains fully on track in terms of its strategy. The cooperation with partners along the value chains was intensified and Lenzing was agile and flexible in adjusting production volume to demand. In addition, Lenzing also intensified measures for structural earnings improvement to mitigate the effect of the pressure on fiber prices and demand for fibers, and reduced its operating costs significantly as a result.

Please read the attached document for more information

• Significant recovery in order intake in third quarter 2020
• Order intake of CHF 425.1 million after nine months
• COVID crisis management in place
• Continuous implementation of the strategy
• Outlook 2020

The market recovery, which Rieter reported in June 2020, has continued. This is reflected in capacity utilization at spinning mills worldwide, which Rieter monitors. In April 2020, the proportion of producing spinning mills was around 40% while at the end of September 2020 this was around 90%. Against this backdrop, the Rieter Group increased order intake in the third quarter of 2020 to CHF 174.4 million (2nd quarter 2020: CHF 45.7 million). In the first nine months of 2020, the Rieter Group achieved a cumulative order intake of CHF 425.1 million (2019: CHF 524.5 million). Compared to the previous year period, this represents a decline of 19%.

Order Intake by Business Group

Due to the positive development in the third quarter of 2020, order intake at the Business Group Machines & Systems reached a total of CHF 234.5 million in the first nine months. The reason for the relatively small decline of 8% compared to the previous year is that the new machinery business was already characterized by investment restraint in the first three quarters of the year 2019. The Business Group Components recorded a reduction of 33% to CHF 116.6 million while the Business Group After Sales posted an order intake of CHF 74.0 million, a decrease of 23%. This illustrates the effects of low capacity utilization at the spinning mills, especially in the second quarter of 2020 as a result of the COVID-19 pandemic. The order backlog as of September 30, 2020, was around CHF 515 million (September 30, 2019: CHF 285 million). Cancellations were in the normal range of around 5%.

COVID Crisis Management in Place

Rieter has quickly implemented comprehensive COVID crisis management. Priority is being given to protecting employees, fulfilling customer commitments and ensuring liquidity. The necessary measures to protect employees have been implemented worldwide and the order backlog is being processed largely as planned. Rieter has introduced 40% short-time working in Switzerland and Germany for the second half of 2020. Similar measures were implemented worldwide within the scope of the available legal options. As of September 30, 2020, Rieter had liquid funds of CHF 216.7 million and unused credit lines in the mid three-digit million range in order to ensure liquidity. At the end of September 2020, net debt of CHF 1.2 million was disclosed.

Continuous Implementation of the Strategy

In recent years, Rieter has consistently implemented the strategy with the focus on innovation leadership, strengthening the business on the installed base and optimization of the costs. The company intends to forge ahead with the strategy in the coming months in order to strengthen the market position for the time after the COVID-19 pandemic. The Rieter CAMPUS is an important element of Rieter’s innovation strategy. Depending on the business situation, construction work is due to begin in the first half of 2021.

Outlook 2020

As already announced, in terms of sales and profitability Rieter expects a stronger second half of the year compared to the first half of 2020. Nevertheless, due to the deferral of deliveries by customers, Rieter will also conclude the second half of the year − and thus the full year 2020 − with a net loss. Due to the existing uncertainties, it continues to be difficult to forecast sales and profitability for the second half of 2020. For this reason, Rieter refrains from providing more specific information for the full year 2020.

Belgian textile innovator Devan Chemicals was lauded by Frost & Sullivan for its antimicrobial technology with proven quaternized silane chemistry, known under its trade name as BI-OME®.

RONSE, BELGIUM – The non-leaching attributes of the technology coupled with its ability to reduce microbial mutation make it a potential candidate for textiles where durability and safe human contact are highly valued.

Based on its recent analysis of the European antimicrobial technology for the textile market, Frost & Sullivan recognizes the Belgium-headquartered Devan Chemicals NV (Devan) with the 2020 European Technology Innovation Leadership Award. Devan’s highly relevant antimicrobial technology addresses issues concerning the contamination of PPE and textiles, including the spread of drug-resistant bacteria, viral transmissions, and hospital-acquired infections (HAIs). Its quat-silane technology, due to its non-migrating behaviour, physically punctures the microorganism cell to destroy it without interfering with cell DNA. Notably, it eliminates the adverse effects of leaching antimicrobials while providing high efficiency in the range of 99.9 percent to 99.99 percent, even after multiple washes.

"By providing non-migrating antimicrobial technology for the textile industry, Devan plugs the safety and performance gaps inherent in current inorganic and organic antimicrobial agents. Its antimicrobial technology, unlike silver- or triclosan-based technology, comprises non-migrating monomers and prepolymers such as organo-functional silane," said Monami Dey, Industry Manager, Frost & Sullivan. "The organo-silane polymers are covalently bonded and polymerized to the textile surface as a coating via padding, exhaust, and spraying techniques. The coating forms a non-leaching reactive surface and destroys the microbes on contact, without releasing harmful components into the environment."

Devan CEO Sven Ghyselinck is very happy with the award: “The best practice award is a nice recognition of the hard work we did in the last 6 months to evaluate the performance against viral activity. It’s great to see our efforts didn’t go unnoticed.”

Earlier this month Devan published new test results confirming the high performance virus-reducing capabilities of its BI-OME fabric coating technology on both unwashed and intensely washed fabrics. The Belgian company has worked closely with a series of international third party laboratories to test different fabric substrates against a wide range of enveloped viruses. Before washing, samples treated with Devan BI-OME score very good to excellent (99% and higher according to ISO 18184) results on virus reduction. Different substrates, like polyester, cotton and polycottons, were exposed to enveloped viruses like SARS-COV-2 (known to cause COVID-19), Feline Corona, Vaccinia (the EU standard for enveloped viruses) and Porcine Respiratory viruses. After 30minutes, BI-OME already reduced 99.96% of the activity of SARS-COV-2.

After washing, a decrease in virus reduction performance of coating technologies is normal and expected. However, BI-OME is confirmed to deliver only a minimal reduction, retaining up to 98.5% virus reduction even when the fabric is washed 25 times.

"Devan is working towards sustainability and green chemistry. For instance, its technology does not contain any harmful solvents such as formaldehyde or polychlorinated phenols and fulfills the regulatory obligations of the EU BPR," noted Dey. "Its commitment to promoting sustainability in textile finishes with a strong focus on GMO-free, kosher, as well as halal certifications, and recyclability has given the company an edge in launching new products at an accelerated pace to match customers’ most pressing concerns and demands."

One of those innovations is BI-OME NTL (natural), a natural, bio-based antimicrobial solution that guarantees an optimal freshness and hygiene for textiles. The active ingredient is the well-known Linseed oil, obtained from the dried, ripened seeds of the flax plant. The active ingredients in BI-OME NTL are GMO free, Halal, Kosher and recyclable.

• The quality of Sappi’s Algro Design Advanced solid bleached board makes the difference for Wolford

The unique combination of physical and optical features combined within the Algro Design range of products, convinced the textile manufacturer, Wolford, to use the range to package its innovative face mask. When creating the packaging solution for its ‘Care Mask’ the company chose to combine the premium 350 gsm Algro Design Advanced solid bleached board with extremely challenging ink covering and a number of finishing options. The end result is a packaging solution that is as elegant as it is creative and as a result, perfectly complements the product inside.

• Premium packaging for premium products
• Perfect for complex graphic applications
• Unique service from the innovation leader Sappi

Wolford, founded in Bregenz, Austria, in 1950, is the global market leader in skinwear ‘made in Europe’. Since its establishment, the company has come up with numerous product innovations and is always at the cutting edge. Even before the coronavirus pandemic hit Europe, product developers were considering the idea of launching their own face mask protection, having witnessed the effects of the coronavirus SARS-CoV-2 in Asia. Thanks to an outstanding, highly efficient development division, a new product, ‘Care Mask’, was quickly brought to market.

It meets the high-quality standards of Wolford and consists of a premium, soft, breathable material that ensures high wearing comfort. Wolford is particularly proud that such a high-quality product could be developed in just a few weeks, despite reduced working hours and staff working from home. It generally takes some time to progress from development to product maturity. In this case however, everything was ready for market launch within two weeks.

Top quality meets top quality

Alongside the product, Wolford developed an appropriate packaging solution for their high-quality product, in collaboration with their in-house graphics department. To enable the ‘Care Mask’ to be quickly launched, a suitable material needed to be found, which could meet Wolford’s high standards in terms of quality, appearance and feel.
 
Wolford’s long-term partner, Sappi Europe had the perfect solution right away with its 350 g/m2 Algro Design Advanced solid bleached board. Thanks to its double-coated top and lightly coated back, the material from the innovation leader is a perfect choice for premium packaging.

The high brightness and silky, soft touch of the paperboard gives the packaging a premium, exclusive look and feel. The colour brilliance of Algro Design Advanced and the continuous, precise reproduction of complex print motifs were exactly what Wolford was looking for and met the high standards of the brand. Thanks to its additional outstanding finishing and processing properties, further processing with grooves, hot-foil embossing, paint finishes and adhesives was also easily achievable, which made it perfect for Wolford’s needs.

Service comes first at Sappi

Product capability alone was not enough for this venture however. To allow Wolford to achieve their goal of two weeks from inception to market ready, they also required a highly responsive service level from their trusted partner and Sappi responded at every level.  From selecting the right quality and size to the precise delivery of the paperboard to the printers, all in the space of five days, Sappi was flexible and immediately ready to respond. Thanks in no small part to the proactive support provided by all contributors to the creative process, the ‘Care Mask’ was launched at the end of March 2020 and was a resounding success. 5,000 masks were sold out within an hour and were sent on their way to the customers in their exclusive packaging.

• Si-Quat by AFFIX Labs is a versatile anti-viral surface treatment that has been scientifically proven to last for months on any surface or textile while effectively killing the COVID-19 pathogen upon contact.
   

Helsinki - Leading chemical binding expert AFFIX Labs has harnessed its global experience in disease prevention to create the first long-lasting surface treatment proven to kill COVID-19. Si-Quat combines a safe and well-established disinfectant and a proprietary chemical binding technique, so that the active ingredient can kill viruses, including SARS-COV-2. Testing at Portugal’s Biochemistry Institute at the University of Lisbon proves that Si-Quat effectively kills the COVID-19 pathogens that it comes into contact with.

“Tragedies have unfolded across the globe, affecting different countries at varying degrees. The second waves of COVID-19 are just appearing on the horizon. This long-lasting surface treatment is a viable, accessible solution across cultures. By killing the COVID-19 pathogen on surfaces before it can infect people, the Si-Quat solution is a game changer. It can provide increased security and peace of mind to your communities, as well as your customers,” says Tom Sam, CEO of AFFIX Labs.

Si-Quat has been tested to kill 99.99% of microbes within minutes, while still being fully safe to touch. Proven to be effective for about a month on frequently touched surfaces, it is the longest lasting anti-viral surface treatment available to reduce the spread of the novel coronavirus. The product is non-corrosive, free from silver salts and heavy metal nanoparticles, and perfectly safe to touch.

Several major agencies around the globe have already accepted quaternary ammonium, the main ingredient in the surface coating, to be an effective surface treatment against the novel coronavirus, including the World Health Organization (WHO), the US Environmental Protection Agency, the American Chemistry Council (ACC) and the European Chemical Agency (ECHA).

Si-Quat was invented in January 2020 by the AFFIX Labs’ Repeltec development team to specifically help combat the COVID-19 outbreak. The product is based on the trusted and safe disinfectant quaternary ammonium, which is chemically bound to align silane quaternary ammonium molecules (silane quats) in a highly effective manner. Positively charged nitrogen particles then actively attract viruses and bacteria, penetrating the membranes and killing them within minutes.

Rigorous testing has shown Si-Quat to adhere to almost any surface, performing as the most durable surface treatment commercially available. Due to its incredibly strong layer, the solution only wears down on surfaces after thousands of touches or multiple cleaning cycles. This means that on heavily used surfaces, such as door handles and counters, Si-Quat will be effective for about a month. On rarely touched surfaces like walls, it has the potential to protect for years. Since the product is incredibly easy to apply, technicians require minimal training and only basic protection. They simply have to brush or spray Si-Quat onto the surface and allow it to dry for 6 hours.

“Other sanitising solutions require reapplication to every surface several times daily, interrupting business operations. This results in additional costs and disruptions at a time when many companies are already struggling,” Sam explains. “By combining proven efficacy, safety and long durability, Si-Quat is emerging as an important weapon in the battle against the spread of COVID-19.”

AFFIX Labs has begun to roll out the distribution of Si-Quat across the globe, with new regions being serviced every week. It is currently looking for distribution partners in local markets.

The project leading to the development of Si-Quat included funding from the European Institute of Innovation and Technology, a body of the European Union, under the Horizon 2020 Framework for Research and Innovation.

• R&D support for textile odor-management according to international testing standards

To ensure responsible use of biocides and international comparability, test methods and test results for antimicrobial treated products must be transparent, useful and comparable. This is precisely why  SANITIZED AG, the specialist for antimicrobial material protection and hygiene function in textiles and polymers, had its in-house Microbiology Laboratory in the SANITIZED TecCenter certified by IAC, the International Antimicrobial Council. This non-profit, U.S.-based institute aims to increase safety for antimicrobial treated products and for consumers. Textile and polymer product manufacturers value the assistance that the in-house SANITIZED TecCenter provides them with developing and optimizing their products. It supervises technical application aspects, and conducts microbiological tests and analytics—all from a single source. SANITIZED provides specific assistance with the textile manufacturer's R&D work, particularly for the demanding challenge of developing the best possible odor-management for textiles. Now the TecCenter has been certified by the IAC and is a designated “International Antimicrobial Council Certified Laboratory.”

Thanks to the IAC Certification, SANITIZED AG now offers innovation expertise according to international standards that are also recognized and valued in the U.S. and Asia.

“In addition to assistance with product development and product optimization from our TecCenter, SANITIZED customers receive certification of the antimicrobial treatment of their products from an independent organization, the IAC,” explains Erich Rohrbach, Head of Microbiology at SANITIZED AG. “This is an important building block for production chain transparency in the textile industry, which is demanded by a growing number of manufacturers and brands that are driven by end customer requirements,” adds Erich Rohrbach. Many SANITIZED customers particularly value the TecCenter for their development work in odor-management for textiles. SANITIZED offers an innovative product portfolio to meet this demand also including non-biocide additives.

• Since the end of March 2020, COVID-19 has led to very low demand in all Business Groups
• Comprehensive crisis management implemented
• Loss in the mid double-digit million range expected in the first half of 2020
• Plans to introduce short-time working to adjust capacity in Switzerland and Germany
• Strategy will continue to be implemented

Due to COVID-19, a large number of spinning mills have stopped production worldwide. Since the end of March 2020, this has led to low demand for spare parts and wear & tear parts and delays in testing programs during the development of new machines. Customers are postponing investment projects or unable to implement them due to restrictions imposed by national governments. This results in low demand for new machines.

Comprehensive crisis management
Rieter has implemented comprehensive crisis management. Priorities are being given to protecting employees, fulfilling customer commitments and ensuring liquidity. The necessary measures to protect employees have been implemented worldwide.
The order backlog of well in excess of CHF 500 million is being processed largely according to plan, despite the existing bottlenecks in the supply chains. Less than 5% of the orders in the order backlog have been canceled.
Rieter has already implemented measures to ensure liquidity and reduce costs. The company has good net liquidity and undrawn credit lines in the mid three-digit million range.
Loss expected in the first half of 2020
As already reported, Rieter expects sales and earnings in the first half of 2020 to be significantly below the prior year level.

Loss expected in the first half of 2020
As already reported, Rieter expects sales and earnings in the first half of 2020 to be significantly below the prior year level. The effects of COVID-19 will place an additional burden on the first half of 2020. Rieter therefore expects sales in the first half of 2020 to be less than CHF 300 million. Despite the countermeasures implemented at the net profit level, this will lead to a loss in the mid double-digit million range.

Plans to introduce short-time working to adjust capacity
Rieter plans to apply for short-time working for the areas with forecasted low capacity utilization at the locations in Switzerland and Germany. The application will be for 40% short-time working in the third quarter of 2020. Talks with staff representatives will begin next week.
As a sign of solidarity, Rieter’s Board of Directors, Group Executive Committee and the senior management will waive 10%-20% of their salaries temporarily.

Implementation of the strategy
In recent years, Rieter has consistently implemented the strategy based on innovation leadership, strengthening the business in components, spare parts and services and the adjustment of cost structures. The company intends to forge ahead with the implementation of the strategy in the coming months, thus strengthening its market position for the time after the COVID-19 pandemic.
The next information on the course of business is planned with the publication of the half-year results on July 16, 2020
 

HeiQ, winner of the Swiss Technology Award and Swiss Environmental Award, launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment that is tested effective against coronavirus.

Since its inception 15 years ago, HeiQ has forged a solid innovation track record helping brands improve textile products. Catalyzed to action by the global fight against Coronavirus, HeiQ launches HeiQ Viroblock NPJ03, an antiviral and antimicrobial textile treatment which is proven effective against human coronavirus (229E) in face mask testing, significantly enhancing the antiviral log reduction from 2.90 of untreated face masks to 4.48, over 99.99% reduction of virus infectivity. (Remarks: a log reduction of 2 is equivalent to 100 times the effectiveness).

Chinese protective masks producer Suzhou Bolisi is the lead adopter of HeiQ Viroblock NPJ03. Treated masks will be available on the market as early as this April. American legwear manufacturer Kayser-Roth is planning to add the technology to their new product, Ghluv hands protector, while Lufeng from China is evaluating the technology on other types of fabric used for garments.

HeiQ Viroblock NPJ03 is a unique combination of vesicle and silver technologies designed to inhibit the growth and persistence of bacteria and viruses. The HeiQ vesicle technology targets lipid- enveloped viruses, such as coronavirus, providing rapid virus deactivation, while the HeiQ silver technology inhibits the replication of both bacteria and viruses. HeiQ Viroblock NPJ03 can be applied to a wide spectrum of textile surfaces including face masks, air filters, medical gowns, curtains, drapes and more. HeiQ also has a range of highly wash-durable antimicrobial and odor control textile technologies, called HeiQ Pure, combining silver-based and bio-based materials for all fabric types.